Regeneron Pharmaceuticals, Inc. planned insider sales
In the last twelve months insiders at Regeneron Pharmaceuticals, Inc. filed 21 Form 144 notices of planned sales, 63,215 shares worth $58.1 million at the time of filing, from 13 sellers. The latest, filed 4 November 2026: Jason Pitofsky (officer), 180 shares worth $175,205, planned for around 4 November 2026 through J.P. Morgan Securities LLC.
| Filed | Seller | Relationship | Shares | Value | Planned sale | Sold, per Form 4 | Broker | How acquired | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 4 November 2026 | Jason Pitofsky | Officer | 180 | $175,205 | 4 November 2026 | None on Form 4 yet | J.P. Morgan Securities LLC | Inherited | Form 144 |
| 4 November 2026 | Jason Pitofsky | Officer | 3,883 | $3.8 million | 4 November 2026 | 4,062 shares from 4 November 2026 | UBS Financial Services Inc | stock option grant | Form 144 |
| 3 November 2026 | Huda Zoghbi | Director | 7,439 | $7.2 million | 3 November 2026 | 7,439 shares from 3 November 2026 | UBS Financial Services Inc | stock option exercise | Form 144 |
| 2 November 2026 | Joseph LaRosa | Officer | 4,466 | $4.3 million | 2 November 2026 | 4,466 shares from 2 November 2026 | UBS Financial Services Inc | Stock Option Exercise | Form 144 |
| 2 November 2026 | Christine Poon | Director | 7,830 | $7.5 million | 2 November 2026 | 7,830 shares from 2 November 2026 | Goldman Sachs & Co. LLC | Stock Options | Form 144 |
| 2 November 2026 | George L. Sing | Director | 21,129 | $20.4 million | 2 November 2026 | 21,129 shares from 2 November 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of Options Under a Registered Plan; Previously Exercised Options | Form 144 |
| 30 October 2026 | Guarini Kathryn | Director | 400 | $360,000 | 30 October 2026 | 400 shares from 30 October 2026 | UBS Financial Services, Inc. | Exercise of stock option | Form 144 |
| 30 October 2026 | McCourt Marion | Officer | 1,132 | $984,195 | 30 October 2026 | 1,132 shares from 30 October 2026 | UBS Financial Services Inc. | RSA Vesting | Form 144 |
| 30 October 2026 | Michael S Brown | Director | 1,929 | $1.6 million | 30 October 2026 | 1,929 shares from 30 October 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of Stock Options | Form 144 |
| 14 October 2026 | Murphy Andrew J | Officer | 4,147 | $3.2 million | 14 October 2026 | 4,147 shares from 14 October 2026 | UBS Financial Services, Inc. | Exercise of Stock Options | Form 144 |
| 3 September 2026 | McCourt Marion | Officer | 1,131 | $969,267 | 3 September 2026 | 2,346 shares from 2 September 2026 | UBS Financial Services Inc. | RSA Vesting | Form 144 |
| 2 September 2026 | Guarini Kathryn | Director | 400 | $340,000 | 2 September 2026 | 400 shares from 2 September 2026 | UBS Financial Services, Inc. | Exercise of stock option | Form 144 |
| 2 September 2026 | McCourt Marion | Officer | 1,215 | $1.0 million | 2 September 2026 | None on Form 4 yet | UBS Financial Services Inc. | RSA Vesting | Form 144 |
| 10 August 2026 | Guarini Kathryn | Board member | 400 | $320,000 | 10 August 2026 | 400 shares from 10 August 2026 | UBS Financial Services, Inc. | Exercise of stock option | Form 144 |
| 10 August 2026 | Zoghbi Huda Y | Director | 800 | $640,000 | 10 August 2026 | 800 shares from 10 August 2026 | UBS Financial Services, Inc. | Exercise of stock options | Form 144 |
| 2 July 2026 | Arthur F. Ryan | Director | 400 | $249,888 | 2 July 2026 | 200 shares from 2 July 2026 | J.P. Morgan Securities LLC | Compensation | Form 144 |
| 19 February 2026 | Zoghbi Huda Y | Director | 1,638 | $1.3 million | 19 February 2026 | 1,638 shares from 19 February 2026 | UBS Financial Services, Inc. | Exercise of stock options | Form 144 |
| 9 February 2026 | Arthur F. Ryan | Director | 400 | $314,204 | 9 February 2026 | 400 shares from 9 February 2026 | J.P. Morgan Securities LLC | Compensation | Form 144 |
| 9 February 2026 | Pitofsky Jason | Officer | 2,036 | $1.6 million | 9 February 2026 | 2,036 shares from 9 February 2026 | UBS Financial Services, Inc. | Exercise of Stock Options; Restricted Stock Award | Form 144 |
| 7 January 2026 | Bassler Bonnie L | Director | 1,500 | $1.2 million | 7 January 2026 | 1,500 shares from 7 January 2026 | RBC CAPITAL MARKETS LLC | OPTION EXERCISE | Form 144 |
| 20 November 2025 | Bassler Bonnie L | Director | 760 | $570,000 | 20 November 2025 | 760 shares from 20 November 2025 | RBC CAPITAL MARKETS LLC | OPTION EXERCISE | Form 144 |
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.